Early Anti-VEGF Isn't Worth Cost in Diabetic Retinopathy
A drug tested on patients with nonproliferative diabetic retinopathy did not improve vision outcomes.
Source: medscape.com
Page 6 - Visual Acuity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Visual Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Visual Acuity Today - Breaking & Trending Today
Pixium Vision announces its consolidated financial
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023 ...
Source: globenewswire.com
SightCare Reviews: The New Supplement Which Promises To Restore Perfect 20/20 Vision without Glasses Is Now Available
SightCare Reviews: The New Supplement Which Promises To Restore Perfect 20/20 Vision without Glasses Is Now Available
Source: texasguardian.com
New NUS Medicine centre leverages AI for community eye disease screening
It has also developed portable screening devices to scale access to eye health care.
Source: healthcareitnews.com
Diabetes Drug Promising for Idiopathic Intracranial Hypertension
In a small phase 2 trial, subcutaneous exenatide led to a significant reduction in intracranial pressure and number of monthly headaches in patients with IIH.
Source: medscape.com